These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28495172)
1. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells. Mitrović A; Pečar Fonović U; Kos J Eur J Cell Biol; 2017 Sep; 96(6):622-631. PubMed ID: 28495172 [TBL] [Abstract][Full Text] [Related]
2. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells. Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
4. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo. He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214 [TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells. Shao JB; Gao ZM; Huang WY; Lu ZB Int J Oncol; 2017 May; 50(5):1623-1633. PubMed ID: 28393230 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells. Gao J; Yan Q; Wang J; Liu S; Yang X J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054 [TBL] [Abstract][Full Text] [Related]
8. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925 [TBL] [Abstract][Full Text] [Related]
9. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of cathepsin L suppresses cancer invasion and migration by inhibiting transforming growth factor‑β‑mediated epithelial‑mesenchymal transition. Zhang Q; Han M; Wang W; Song Y; Chen G; Wang Z; Liang Z Oncol Rep; 2015 Apr; 33(4):1851-9. PubMed ID: 25632968 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells. Gerber A; Wille A; Welte T; Ansorge S; Bühling F J Interferon Cytokine Res; 2001 Jan; 21(1):11-9. PubMed ID: 11177576 [TBL] [Abstract][Full Text] [Related]
13. Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells. Chen ZY; Wang PW; Shieh DB; Chiu KY; Liou YM J Biomed Sci; 2015 Oct; 22():90. PubMed ID: 26482896 [TBL] [Abstract][Full Text] [Related]
14. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1. Trivanović D; Jauković A; Krstić J; Nikolić S; Okić Djordjević I; Kukolj T; Obradović H; Mojsilović S; Ilić V; Santibanez JF; Bugarski D IUBMB Life; 2016 Mar; 68(3):190-200. PubMed ID: 26805406 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
17. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Lv M; Li Y; Ji MH; Zhuang M; Tang JH Mol Med Rep; 2014 Jul; 10(1):341-6. PubMed ID: 24756435 [TBL] [Abstract][Full Text] [Related]
20. Elevated TGF-β1 and -β2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells. Kim S; Lee J; Jeon M; Nam SJ; Lee JE Cytokine; 2015 Sep; 75(1):151-8. PubMed ID: 26088755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]